LB Pharmaceuticals Inc

Research LB Pharmaceuticals Inc (LBRX) on Bullrun: market cap USD 936.01M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLBRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 936.01M
• Financial periodFY2025
• Net income-USD 25.21M
• Free cash flow-USD 35.26M

Valuation Snapshot

latest market cap is USD 936.01M.

About LB Pharmaceuticals Inc

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation.

Frequently asked questions

What is LB Pharmaceuticals Inc's market cap?

LB Pharmaceuticals Inc's market capitalization is USD 936.01M.

What does LB Pharmaceuticals Inc do?

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.